Huntington National Bank Seagen Inc. Transaction History

Huntington National Bank

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$191.51 - $216.16 $1,149 - $1,296	6 Added 11.76%	57 $12,000
Q2 2023 Aug 11, 2023	BUY	$187.64 - $206.25 $6,192 - $6,806	33 Added 183.33%	51 $9,000
Q1 2023 May 10, 2023	BUY	$127.59 - $203.08 $2,296 - $3,655	18 New	18 $3,000
Q3 2022 Nov 07, 2022	BUY	$135.27 - $180.11 $676 - $900	5 New	5 $0
Q1 2021 Apr 12, 2021	SELL	$137.51 - $190.8 $3,850 - $5,342	-28 Closed	0 $0

Q4 2020 Jan 11, 2021	BUY	$164.63 - $211.93 $4,609 - $5,934	28 New	28 $5,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

Stay updated on Huntington National Bank with notifications on news.